Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-18-010732

Chief Technology Officer sold 7,000 shares at an average $29.78 ($208,430)

  • Chief Technology Officer acquired 7,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myer Vickesh Chief Technology Officer 2018-08-17 Option exercise +3,000 $0.65 $1,950 3,000 D
Myer Vickesh Chief Technology Officer 2018-08-17 Sale −3,000 $29.65 $88,950 0 D
Myer Vickesh Chief Technology Officer 2018-08-20 Option exercise +3,600 $11.21 $40,356 3,600 D
Myer Vickesh Chief Technology Officer 2018-08-20 Sale −3,600 $29.81 $107,316 0 D
Myer Vickesh Chief Technology Officer 2018-08-20 Option exercise +400 $11.21 $4,484 400 D
Myer Vickesh Chief Technology Officer 2018-08-20 Sale −400 $30.41 $12,164 0 D
Derivatives
Myer Vickesh Chief Technology Officer 2018-08-17 Option exercise · Stock Option (right to buy) −3,000 94,307 D
Myer Vickesh Chief Technology Officer 2018-08-20 Option exercise · Stock Option (right to buy) −4,000 72,897 D
Open-market sales · 7,000 sh · avg $29.78 · $208,430
Loading xslF345X03/edgar.xml…